Publikationen, an denen er mitarbeitet Santiago Moreno Guillén (36)

2024

  1. Impact of an Intervention Program on Clostridioides difficile Infections: Comparison of 2 Hospital Cohorts

    Open Forum Infectious Diseases, Vol. 11, Núm. 7

  2. Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?

    Age and Ageing, Vol. 53, Núm. 8

2023

  1. Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection

    Journal of Fungi, Vol. 9, Núm. 2

  2. Sexually transmitted infections in Spain: Current status

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 444-465

2022

  1. Carbapenemase-producing Enterobacterales infections in COVID-19 patients

    Infectious Diseases, Vol. 54, Núm. 1, pp. 36-45

2021

  1. Usefulness of fecal calprotectin in the management of patients with toxigenic clostridioides difficile

    Journal of Clinical Medicine, Vol. 10, Núm. 8

2020

  1. What Should Be Known by a Urologist About the Medical Management of COVID-19’s Patients?

    Current Urology Reports, Vol. 21, Núm. 10

2014

  1. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3134-3141

2013

  1. Diseño y realización de talleres de preparación y entrenamiento para la prueba ECOE (Evaluación Clínica Objetiva Estructurada)

    Docentes y estudiantes dialogando: hacia una comprensión de la participación en la universidad (Editorial Universidad de Alcalá), pp. 313-324

  2. Infective endocarditis in congenital heart disease: A frequent community-acquired complication

    Infection, Vol. 41, Núm. 1, pp. 167-174

2012

  1. Emerging trends in candidemia: A higher incidence but a similar outcome

    Journal of Infection, Vol. 65, Núm. 1, pp. 64-70

  2. Very late initiation of HAART impairs treatment response at 48 and 96 weeks: Results from a meta-analysis of randomized clinical trials

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 2, pp. 312-321

2011

  1. Changes in the epidemiology of tuberculosis: The influence of international migration flows

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 9, pp. 654-659

2009

  1. Influence of microbiological reports on physician's choice of antimicrobial treatment for susceptible pathogens (European Journal of Clinical Microbiology and Infectious Diseases (2003) 22 (569-572) DOI:10.1007/s10096-003-0978-3)

    European Journal of Clinical Microbiology and Infectious Diseases

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

  2. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria

    Journal of Infection, Vol. 56, Núm. 3, pp. 185-190

  3. Tratamiento de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antirretroviral de gran actividad. Recomendaciones del Grupo de Estudio del Sida (GESIDA)/Plan Nacional sobre el Sida

    Enfermedades Infecciosas y Microbiologia Clinica

2007

  1. Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation?

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 794-798

  2. Trends in neurological complications of endocarditis

    Journal of Neurology, Vol. 254, Núm. 9, pp. 1253-1259

2006

  1. Candidemia in pediatric patients with congenital heart disease

    Diagnostic Microbiology and Infectious Disease, Vol. 55, Núm. 3, pp. 203-207